156 related articles for article (PubMed ID: 16508761)
1. Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected.
Kuypers KP; Ramaekers JG
Psychopharmacology (Berl); 2007 Jan; 189(4):557-63. PubMed ID: 16508761
[TBL] [Abstract][Full Text] [Related]
2. Stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal.
Ramaekers JG; Kuypers KP; Samyn N
Addiction; 2006 Nov; 101(11):1614-21. PubMed ID: 17034441
[TBL] [Abstract][Full Text] [Related]
3. Transient memory impairment after acute dose of 75mg 3.4-Methylene-dioxymethamphetamine.
Kuypers KP; Ramaekers JG
J Psychopharmacol; 2005 Nov; 19(6):633-9. PubMed ID: 16272186
[TBL] [Abstract][Full Text] [Related]
4. Involvement of inferior parietal lobules in prospective memory impairment during acute MDMA (ecstasy) intoxication: an event-related fMRI study.
Ramaekers JG; Kuypers KP; Wingen M; Heinecke A; Formisano E
Neuropsychopharmacology; 2009 Jun; 34(7):1641-8. PubMed ID: 19092784
[TBL] [Abstract][Full Text] [Related]
5. MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.
Kuypers KP; Samyn N; Ramaekers JG
Psychopharmacology (Berl); 2006 Sep; 187(4):467-75. PubMed ID: 16830130
[TBL] [Abstract][Full Text] [Related]
6. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.
Parrott AC; Lees A; Garnham NJ; Jones M; Wesnes K
J Psychopharmacol; 1998; 12(1):79-83. PubMed ID: 9584971
[TBL] [Abstract][Full Text] [Related]
7. Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4 h apart Human pharmacology of MDMA after repeated doses taken 4 h apart.
Farré M; Tomillero A; Pérez-Mañá C; Yubero S; Papaseit E; Roset PN; Pujadas M; Torrens M; Camí J; de la Torre R
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1637-49. PubMed ID: 26073279
[TBL] [Abstract][Full Text] [Related]
8. Visuospatial memory impairments in users of MDMA ('ecstasy').
Wareing M; Murphy PN; Fisk JE
Psychopharmacology (Berl); 2004 May; 173(3-4):391-7. PubMed ID: 14735294
[TBL] [Abstract][Full Text] [Related]
9. Memory and mood during the night and in the morning after repeated evening doses of MDMA.
Kuypers KP; Wingen M; Ramaekers JG
J Psychopharmacol; 2008 Nov; 22(8):895-903. PubMed ID: 18974173
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol.
Ramaekers JG; Kuypers KP
Neuropsychopharmacology; 2006 May; 31(5):1048-55. PubMed ID: 16160704
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination.
Hysek CM; Simmler LD; Schillinger N; Meyer N; Schmid Y; Donzelli M; Grouzmann E; Liechti ME
Int J Neuropsychopharmacol; 2014 Mar; 17(3):371-81. PubMed ID: 24103254
[TBL] [Abstract][Full Text] [Related]
12. Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance.
Lamers CT; Ramaekers JG; Muntjewerff ND; Sikkema KL; Samyn N; Read NL; Brookhuis KA; Riedel WJ
J Psychopharmacol; 2003 Dec; 17(4):379-87. PubMed ID: 14870949
[TBL] [Abstract][Full Text] [Related]
13. MDMA affects both error-rate dependent and independent aspects of decision-making in a two-choice prediction task.
Vollenweider FX; Liechti ME; Paulus MP
J Psychopharmacol; 2005 Jul; 19(4):366-74. PubMed ID: 15982991
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of MDMA-induced increase in cortisol does not prevent acute impairment of verbal memory.
Kuypers KP; de la Torre R; Farre M; Pujadas M; Ramaekers JG
Br J Pharmacol; 2013 Feb; 168(3):607-17. PubMed ID: 22946487
[TBL] [Abstract][Full Text] [Related]
15. Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers.
Dumont GJ; Schoemaker RC; Touw DJ; Sweep FC; Buitelaar JK; van Gerven JM; Verkes RJ
J Psychopharmacol; 2010 Feb; 24(2):155-64. PubMed ID: 19164498
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.
Farré M; Abanades S; Roset PN; Peiró AM; Torrens M; O'Mathúna B; Segura M; de la Torre R
J Pharmacol Exp Ther; 2007 Dec; 323(3):954-62. PubMed ID: 17890444
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans.
Mas M; Farré M; de la Torre R; Roset PN; Ortuño J; Segura J; Camí J
J Pharmacol Exp Ther; 1999 Jul; 290(1):136-45. PubMed ID: 10381769
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of MDMA and methylphenidate on social cognition.
Schmid Y; Hysek CM; Simmler LD; Crockett MJ; Quednow BB; Liechti ME
J Psychopharmacol; 2014 Sep; 28(9):847-56. PubMed ID: 25052243
[TBL] [Abstract][Full Text] [Related]
19. Human Pharmacology of Mephedrone in Comparison with MDMA.
Papaseit E; Pérez-Mañá C; Mateus JA; Pujadas M; Fonseca F; Torrens M; Olesti E; de la Torre R; Farré M
Neuropsychopharmacology; 2016 Oct; 41(11):2704-13. PubMed ID: 27206266
[TBL] [Abstract][Full Text] [Related]
20. MDMA intoxication and verbal memory performance: a placebo-controlled pharmaco-MRI study.
Kuypers KP; Wingen M; Heinecke A; Formisano E; Ramaekers JG
J Psychopharmacol; 2011 Aug; 25(8):1053-61. PubMed ID: 21616977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
